logo

Array Biopharma Inc. (ARRY)



Trade ARRY now with
  Date
  Headline
2/6/2018 8:07:37 AM Array BioPharma Q2 Total Revenue $42.2 Mln Vs. $44.5 Mln Last Year
2/6/2018 8:04:58 AM Array BioPharma And Pierre Fabre Report Results Of Planned Analysis Of OS From Pivotal Phase 3 COLUMBUS Trial
1/20/2018 8:23:11 PM Array BioPharma, Pierre Fabre Reveal Updated Results From BEACON CRC Trial
1/16/2018 8:05:07 AM Array BioPharma To Present Updated Phase 3 BEACON CRC Safety Lead-In Results Of The Combination Of Encorafenib
12/19/2017 8:02:51 AM Array BioPharma Enters Clinical Trial Collaboration Agreement With Pfizer
11/13/2017 8:04:02 AM Array BioPharma Reports Data From Phase 1b Clinical Trial On Immunotherapy Combination Of ARRY-382 With Merck's KEYTRUDA
10/31/2017 8:03:40 AM Array BioPharma Q1 Net Loss $38.0 Mln Or $0.22/shr Vs Loss $28.6 Mln Or $0.20/Shr Last Year
9/19/2017 9:13:37 AM Array BioPharma Closes Its Underwritten Public Offering Of 24.07 Mln Common Shares
9/13/2017 4:07:02 PM Array BioPharma Announces Proposed Public Offering Of Common Stock